BPC-157 and Thymosin Alpha-1 for Spinal Disc Recovery After the FDA Panel Vote
The FDA panel's recent vote has renewed interest in BPC-157 and Thymosin Alpha-1 for spinal disc repair. Preclinical data show early signals...
Read more →FROM THE LAB JOURNAL
Guides, protocols, and the science behind verified peptides.
The FDA panel's recent vote has renewed interest in BPC-157 and Thymosin Alpha-1 for spinal disc repair. Preclinical data show early signals...
Read more →BPC-157 shows promise in animal models of rotator cuff repair, but newer peptides like Pentadeca Arginate are gaining research traction. The FDA...
Read more →A research-focused comparison of Pentadeca Arginate and BPC-157 for post-surgery tendon repair, examining speed, mechanism, and evidence after the
Read more →